Abstract
Substantial change to the regulation of medical devices in both the UK and Canada, and the development of a mutual recognition agreement which affects the two jurisdictions, raises concerns about the possibility of balancing the need for flexibility regarding the industry and trade on the one hand, and the public interest in health and safety on the other.
Get full access to this article
View all access options for this article.
